Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Nadine A. Kahle
Observed names:
N. Kahle,
N.A. Kahle,
Nadine Kahle
Institutions:
Universitätsklinikum Tübingen,
University of Tübingen
Observed institutions:
Heidelberg University,
Robert Bosch Hospital,
Universitätsklinikum Tübingen,
Dr. Margarete Fischer-Bosch-Institute of Clinical Pharmacology,
STZ eyetrial,
Institut für Immunologie,
University of Tübingen
show all 7
OpenAlex ID:
A5034341833
Safety and Vision Outcomes of Subretinal Gene Therapy Targeting Cone Photoreceptors in Achromatopsia: A Nonrandomized Controlled Trial
2020
·
M. Dominik Fischer
, Stylianos Michalakis
, et al.
·
JAMA Ophthalmology
·
206
PDF
Tasting Pseudomonas aeruginosa Biofilms: Human Neutrophils Express the Bitter Receptor T2R38 as Sensor for the Quorum Sensing Molecule N-(3-Oxododecanoyl)-l-Homoserine Lactone
2015
·
Susanne Maurer
, Guido H. Wabnitz
, et al.
·
Frontiers in Immunology
·
149
PDF
Efficacy and Safety of Retinal Gene Therapy Using Adeno-Associated Virus Vector for Patients With Choroideremia: A Randomized Clinical Trial
2019
·
M. Dominik Fischer
, G. Alex Ochakovski
, et al.
·
JAMA Ophthalmology
·
98
PDF
Three-year results of phase I retinal gene therapy trial for CNGA3-mutated achromatopsia: results of a non randomised controlled trial
2021
·
Felix Friedrich Reichel
, Stylianos Michalakis
, et al.
·
British Journal of Ophthalmology
·
85
Changes in Retinal Sensitivity After Gene Therapy in Choroideremia
2018
·
M. Dominik Fischer
, G. Alex Ochakovski
, et al.
·
Retina
·
67
Bacterial quorum sensing molecule induces chemotaxis of human neutrophils via induction of p38 and leukocyte specific protein 1 (LSP1)
2012
·
N.A. Kahle
, G. Brenner-Weiss
, et al.
·
Immunobiology
·
30
Development of Methodology and Study Protocol: Safety and Efficacy of a Single Subretinal Injection of rAAV.hCNGA3 in Patients with CNGA3 -Linked Achromatopsia Investigated in an Exploratory Dose-Escalation Trial
2018
·
Nadine A. Kahle
, Tobias Peters
, et al.
·
Human Gene Therapy Clinical Development
·
27
Safety and Toxicology of Ocular Gene Therapy with Recombinant AAV Vector rAAV.hCNGA3 in Nonhuman Primates
2019
·
Peters Tobias
, Seitz Immanuel Philipp
, et al.
·
Human Gene Therapy Clinical Development
·
26
Galectin-3 inhibits the chemotaxis of human polymorphonuclear neutrophils in vitro
2011
·
Billur Baseras
, Matthias M. Gaida
, et al.
·
Immunobiology
·
21
Transkorneale Elektrostimulation bei Retinitis pigmentosa: Prüfplan einer multizentrischen, prospektiven, randomisierten, kontrollierten und doppelblinden Studie im Auftrag des Gemeinsamen Bundesausschusses (G-BA-Erprobungsrichtlinie)
2021
·
retina.net e. V.
, Nadine Kahle
, et al.
·
Der Ophthalmologe
·
4
PDF
How do patients rate their subjective symptoms after CNGA3 gene therapy: First application of the instrument A3-PRO
2017
·
Barbara Wilhelm
, Andreas Koegel
, et al.
·
Investigative Ophthalmology & Visual Science
·
4
Zusammenarbeit mit klinischen Auftragsforschungsinstituten: Vorstellung eines Fragebogens für klinische Studienzentren
2021
·
Adeline Adorf
, Katrin Lorenz
, et al.
·
Die Ophthalmologie
·
2
PDF
Interaktion des bakteriellen Quorum Sensing Moleküls N-(3-oxododecanoyl)-L-Homoserin-Lacton (AHL-12) mit humanen neutrophilen Granulozyten
2013
·
Nadine Kahle
·
University writing server of the University of Hohenheim (Universität Hohenheim)
·
2
PDF
Furin Cleavage of Bacterial Expressed Glutathione-S-Transferase-Pro-Transforming Growth Factor β1 Fusion Protein In Vitro
2010
·
N. Kahle
, C. Joffroy
, et al.
·
Protein and Peptide Letters
·
2
Wegweisende Studien in der Augenheilkunde – von der klinischen Studie zur Leitlinientherapie
2026
·
Immanuel Philipp Seitz
, Melanie Ziegler
, et al.
·
Die Ophthalmologie
PDF
Show more works
View as search
Works count:
16
Citation count:
723
H-index:
9
I10-index:
9
Year
Topic
Type